irritable%20bowel%20syndrome
IRRITABLE BOWEL SYNDROME
Irritable bowel syndrome is a common chronic gastrointestinal condition characterized by abdominal pain and bloating with altered bowel habits.
There are no identifiable physical, radiologic or lab abnormalities indicative of organic disease.
Symptoms may be exacerbated by stress, alcohol or food.

Irritable Bowel Syndrome Drug Information

Drug Information

Indication: Spasmodic pain, oesophageal spasm, cholecystitis, choledocholithiasis, dysuria & pollakisuria, spasmodic d...

Indication: Acute spasm, as in renal or biliary chronic, radiology for differential diagnosis of obstruction. Reduce spasm...

Indication: Relief of constipation eg, constipation in pregnancy & maintenance of regularity. Bowel function managemen...

Indication: Constipation, hepatic encephalopathy.

Indication: Adjunctive therapy in treatment of peptic ulcer, irritable bowel syndrome & acute enterocolitis.

Indication: Control & symptomatic relief of acute nonspecific diarrhoea & chronic diarrhoea associated w/ inflamma...

Meteospasmyl
alverine citrate + simethicone

Indication: Antispasmodic that reduces intestinal gas. Relieves painful digestion accompanied by stomach distension. Relie...

Indication: Constipation & portal systemic encephalopathy.

Indication: Pre-anaesth medication in conjugation w/ morphine sulphate. Reverse the effects of non-depolarising muscle rel...

Indication: Acute & chronic diarrhoea. Pain associated w/ oesogastroduodenal & colic disease.

2  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.